EFFECT OF RENAL-TRANSPLANTATION ON PLASMA-PROTEIN BINDING

被引:4
作者
AFFRIME, MB [1 ]
BLECKER, DL [1 ]
LYONS, PJ [1 ]
PITONE, JM [1 ]
SWARTZ, CD [1 ]
LOWENTHAL, DT [1 ]
机构
[1] HAHNEMANN MED COLL & HOSP,DEPT PHARMACOL,PHILADELPHIA,PA 19102
来源
JOURNAL OF DIALYSIS | 1979年 / 3卷 / 2-3期
关键词
D O I
10.3109/08860227909063941
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The in vitro plasma protein binding was determined in nine maintenance hemodialysis patients who later underwent renal transplantation. The organic acid fluorescein (10 ug/ml) or the organic base quinidine (5 ug/ml) was added to the pre and post transplant serum of these patients. Drug concentrations were measured spectrophotofluorometrically after equilibrium dialysis. The results were compared with the plasma protein binding of eight normal volunteers. The patients on maintenance hemodialysis had lower plasma protein binding of fluorescein than normals (78 ± 5% vs 89 ± 4, p < 0.001). Plasma protein binding improved significantly after renal transplantation (85 ± 3, p < 0.01) but was still lower than in normals (p < 0.05). Plasma protein binding of quinidine was not significantly different than in normal volunteers (77 ± 8% either prior to (72 ± 10% or after (73 ± 12% kidney transplantation. Plasma protein binding of quinidine remains unaffected by renal transplantation. However, the abnormal plasma protein binding of organic acids in chronic renal failure may be significantly improved by renal transplantation. © 1979 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:207 / 218
页数:12
相关论文
共 13 条
[1]  
ANDREASEN F, 1974, ACTA PHARMACOL TOX, V34, P284
[2]  
BORGA O, 1978, PHARMACOLOGY, V16, P37
[3]  
DROOMGOOLE SH, 1974, CLIN CHEM ACTA, V52, P301
[4]   BINDING OF HIPPURATE IN NORMAL PLASMA AND IN UREMIC PLASMA PRE-DIALYSIS AND POST-DIALYSIS [J].
FARRELL, PC ;
GOTCH, FA ;
PETERS, JH ;
BERRIDGE, BJ ;
LAM, M .
NEPHRON, 1978, 20 (01) :40-46
[5]  
LEVY G, 1976, CLIN PHARMACOL THER, V20, P512
[6]   PLASMA-PROTEIN BINDING OF PHENYTOIN AND WARFARIN IN PATIENTS UNDERGOING RENAL-TRANSPLANTATION [J].
ODARCEDERLOF, I .
CLINICAL PHARMACOKINETICS, 1977, 2 (02) :147-153
[7]   LACK OF RELATIONSHIP BETWEEN SERUM FREE FATTY-ACIDS AND IMPAIRED PLASMA-PROTEIN BINDING OF DIPHENYLHYDANTOIN IN CHRONIC RENAL-FAILURE [J].
ODARCEDERLOF, I ;
BORGA, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (06) :403-405
[8]  
REIDENBERG M M, 1976, Clinical Pharmacokinetics, V1, P121, DOI 10.2165/00003088-197601020-00003
[9]   PROTEIN BINDING OF DIPHENYLHYDANTOIN AND DESMETHYLIMIPRAMINE IN PLASMA FROM PATIENTS WITH POOR RENAL FUNCTION [J].
REIDENBERG, MM ;
ODARCEDE.I ;
BAHR, CV ;
BORGA, O ;
SJOQVIST, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (05) :264-+
[10]  
REIDENBERG MM, 1973, ANN NY ACAD SCI, V226, P333